Improved survival in psoriatic arthritis with calendar time

Arthritis and Rheumatism

Volumn 56, Issue 8, 2007, Pages 2708-2714

  Ali, Yaser ^a   Tom, Brian D M ^b   Schentag, Catherine T ^a   Farewell, Vernon T ^b   Gladman, Dafna D ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANADA; CAUSE OF DEATH; CLINICAL FEATURE; COHORT ANALYSIS; DISEASE SEVERITY; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSORIATIC ARTHRITIS; RISK ASSESSMENT; SURVIVAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, PSORIATIC; CANADA; CAUSE OF DEATH; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SURVIVAL RATE; TIME;

EID: 34547770224     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.22800     Document Type: Article

References (26)

1. Gladman DD. Psoriatic arthritis. In: Harris ED, Budd RC, Firestein GS, Genovese MC, Sergent JS, Ruddy S, Sledge CB, editors. Kelley's textbook of rheumatology. 7th ed. Philadelphia: Saunders Elsevier; 2004. p. 1155-64.
2. Wright V. Psoriatic arthritis: a comparative study of rheumatoid arthritis and arthritis associated with psoriasis. Ann Rheum Dis 1961;20:123-31.
3. Scarpa R, della Valle G, Lubrano E, di Girolamo C, Del Puente A, Oriente P. Psoriatic arthritis: a harmless disease? [letter]. Br J Rheumatol 1992;31:210-1.
4. Coulton BL, Thomson K, Symmons DP, Popert AJ. Outcomes in patients hospitalized for psoriatic arthritis. Clin Rheumatol 1989;8:261-5.
5. Gladman DD, Shuckett R, Russell ML, Thome JC, Schachter RK. Psoriatic arthritis (PSA) - an analysis of 220 patients. Q J Med 1987;62:127-41.
6. Torre Alonso JC, Rodrigues Perez A, Arribas Castrillo JM, Ballina Garcia J, Riestra Noriega JL, Lopez Larrea C. Psoriatic arthritis (PA): a clinical, immunologic and radiological study of 180 patients. Br J Rheumatol 1991;30:245-50.
7. Kane D, Stafford L, Bresniham B, FitzGerald O. A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatology (Oxford) 2003;42:1460-8.
8. Queiro-Silva R, Torre-Alonso JC, Tinture-Eguren T, Lopez-Lagunas I. A polyarticular onset predicts erosive and deforming disease in psoriatic arthritis. Ann Rheum Dis 2003;62:68-70.
9. McHugh NJ, Balachrishnan C, Jones SM. Progression of peripheral joint disease in psoriatic arthritis: a 5-yr prospective study. Rheumatology (Oxford) 2003;42:778-83.
10. Wong K, Gladman DD, Husted J, Long JA, Farewell VT. Mortality studies in psoriatic arthritis: results from a single outpatient clinic. I. Causes and risk of death. Arthritis Rheum 1997;40:1868-72.
11. Shbeeb M, Uramoto KM, Gibson LE, O'Fallon WM, Gabriel SE. The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991. J Rheumatol 2000;27:1247-50.
12. Wright V, Moll JM. Psoriatic arthritis. In: Wright V, Moll JM, editors. Seronegative polyarthritis. Amsterdam: North Holland Publishing; 1976. p. 169-232.
13. Sokoll KB, Helliwell PS. Comparison of disability and quality of life in rheumatoid arthritis and psoriatic arthritis. J Rheumatol 2001;28:1842-6.
14. Rahman P, Nguyen E, Cheung C, Schentag C, Gladman DD. Comparison of radiological severity in psoriatic arthritis and rheumatoid arthritis. J Rheumatol 2001;28:1041-4.
15. Husted JA, Gladman DD, Farewell VT, Cook RJ. Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis. Arthritis Rheum 2001;45:151-8.
16. Gladman DD. Natural history of psoriatic arthritis. Baillieres Clin Rheumatol 1994;8:379-94.
17. Gladman DD, Farewell VT, Nadeau C. Clinical indicators of progression in psoriatic arthritis (PSA): multivariate relative risk model. J Rheumatol 1995;22:675-9.
18. Gladman DD, Farewell VT. Progression in psoriatic arthritis: role of time varying clinical indicators. J Rheumatol 1999;26:2409-13.
19. Gladman DD, Hing EN, Schentag CT, Cook RJ. Remission in psoriatic arthritis. J Rheumatol 2001;28:1045-8.
20. Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, et al. The mortality of rheumatoid arthritis. Arthritis Rheum 1994;37:481-94.
21. Mikuls TR, Saag KG, Criswell LA, Merlino LA, Kaslow RA, Shelton BJ, et al. Mortality risk associated with rheumatoid arthritis in a prospective cohort of older women: results from the Iowa Women's Health Study. Ann Rheum Dis 2002;61:994-9.
22. Hakoda M, Oiwa H, Kasagi F, Masunari N, Yamada M, Suzuki G, et al. Mortality of rheumatoid arthritis in Japan: a longitudinal cohort study. Ann Rheum Dis 2005;64:1451-5.
23. Gladman DD, Farewell VT, Wong K, Husted J. Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for mortality. Arthritis Rheum 1998;41:1103-10.
24. Turesson C, O'Fallon WM, Crowson CS, Gabriel SE, Matteson EL. Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. J Rheumatol 2002;29:62-7.
25. Chandran V, Bhella S, Schentag CT, Gladman DD. The FACIT-Fatigue Scale is valid in patients with psoriatic arthritis (PsA) [abstract]. Arthritis Rheum 2005;52:4084.
26. Bond S, Farewell VT, Schentag CT, Lawless JF, Gladman DD. Reporting of mortality in a psoriatic arthritis clinic is primarily a function of the number of clinic contacts and not disease severity. J Rheumatol 2005;32:2364-7.